PubMed Health⌕ Search

PubMed · 6502694

Volume regulation by Necturus gallbladder: basolateral KCl exit.

Abstract

Swelling of the epithelial cells of Necturus gallbladder caused by an 18% reduction in the osmolality of the mucosal bath is followed by rapid volume readjustment. This volume regulatory decrease requires Cl and is sensitive to the K and Cl gradients across the basolateral cell membrane. Volume regulatory decrease is not inhibited by amiloride, SITS, ouabain or bicarbonate removal. The process is blocked by bumetanide in the serosal bath. Measurement of the intracellular activities of K and Cl and the rate of volume regulation under five different experimental conditions showed that KCl exited from the cell across the basolateral membrane with a stoichiometry of 3 K to 2 Cl. This KCl exit process appears to be transiently activated following the reduction in osmolality of the mucosal perfusate.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Larson, K R Spring. 1984. Volume regulation by Necturus gallbladder: basolateral KCl exit.. https://doi.org/10.1007/bf01868715

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The electrogenic Na+/HCO3- cotransport modulates resting membrane potential and action potential duration in cat ventricular myocytes.

Perforated whole-cell configuration of patch clamp was used to determine the contribution of the electrogenic Na+/HCO3- cotransport (NBC) on the shape of the action potential in cat ventricular myocytes. Switching from Hepes to HCO3- buffer at constant extracellular pH (pH(o)) hyperpolarized resting membrane potential (RMP) by 2.67 +/- 0.42 mV (n = 9, P < 0.05). The duration of action potential measured at 50% of repolarization time (APD50) was 35.8 +/- 6.8% shorter in the presence of HCO3- than in its absence (n = 9, P < 0.05). The anion blocker SITS prevented and reversed the HCO3- -induced hyperpolarization and shortening of APD. In addition, no HCO3- -induced hyperpolarization and APD shortening was observed in the absence of extracellular Na+. Quasi-steady-state currents were evoked by 8 s duration voltage-clamped ramps ranging from -130 to +30 mV. A novel component of SITS-sensitive current was observed in the presence of HCO3-. The HCO3- -sensitive current reversed at -87 +/- 5 mV (n = 7), a value close to the expected reversal potential of an electrogenic Na+/HCO3- cotransport with a HCO3-:Na+ stoichiometry ratio of 2: 1. The above results allow us to conclude that the cardiac electrogenic Na+/HCO3- cotransport has a relevant influence on RMP and APD of cat ventricular cells.

4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfo↗

Band 3 (AE1, SLC4A1)-mediated transport of stilbenedisulfonates. I: Functional identification of the proton-activated stilbenedisulfonate influx site.

Stilbenedisulfonates (SD) bind to a "primary" SD (PSD) site on the outer membrane surface of band 3, and inhibit anion exchange (AE) allosterically. Yet, evidence [Membr. Biochem. 2 (1979) 297] suggests that SD can be transported by band 3, thus raising questions about the relative locations of the transport and SD binding sites. A "second" class of DBDS (4,4'-dibenzamido-2,2'-stilbenedisulfonate) binding sites has been discovered, which is activated by protons (pK approximately 5.0), and is located on the membrane domain of band 3 [Biochem. J. 388 (2005) 343]. Here we show that the "second" class of DBDS binding sites, not the PSD site, lies on the SD transport pathway. We compare the pH dependence of DBDS influx to DBDS binding using: (a) control cells, (b) cells selectively crosslinked at the PSD site by treatment with 300 microM BS3 (bis(sulfosuccinimidyl)suberate), and (c) cells with DIDS (4,4'-diisothiocyanato-2,2'-stilbenedisulfonate) bound covalently to the PSD site. DBDS binds to the "second" class of sites on band 3 in all three types of cells. DBDS does not bind to the PSD sites of BS3- or DIDS-modified cells. Proton-activated DBDS influx was observed using control and BS3-modified cells, but not when using DIDS-modified cells. The results with DIDS suggest that the PSD site and the transport site overlap. However, this interpretation is disproved by experiments with BS3-modified cells, where the PSD site is blocked, yet DBDS transport and binding to the "second" class of sites both take place.

4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfo↗

Band 3 (AE1, SLC4A1)-mediated transport of stilbenedisulfonates. II: Evidence for transmembrane allosteric interactions between the "primary" stilbenedisulfonate binding site and the stilbenedisulfonate efflux site.

Results from the first paper in this series indicated that the "primary" stilbenedisulfonate (PSD) site was not located on the DBDS (4, 4'-dibenzamido-2, 2'-stilbenedisulfonate) transport pathway into magnesium resealed ghosts (MRSG). Rather, transport correlated with DBDS binding to the "second" class of proton-activated binding sites located on the membrane domain of band 3 [Biochem. J. 388 (2005) 343]. Here we report the discovery that reversible binding of extracellular H2DIDS (4, 4'-diisothiocyanatodihydro-2, 2'-stilbenedisulfonate) to the PSD site causes a greater than 5-fold acceleration in the rate of DBDS efflux from pre-loaded MRSG at physiological pH. Pre-labeling all of the PSD sites with H2DIDS inhibited the acceleration effect completely, thus confirming mediation by band 3. Acceleration of DBDS efflux could be mimicked by establishing an externally directed proton gradient (acidic inside, pH 7.4 outside). Under these conditions, addition of extracellular H2DIDS neither accelerated DBDS efflux further nor was proton-induced acceleration inhibited. The results of this paper support the view that the PSD binding site on band 3 is an allosteric regulatory site which is not located on the SD transport pathway. We propose a model where H2DIDS binding to the PSD site modulates activity at the "second" class of sites by raising the pK for transport of DBDS into the physiological pH range.

4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfo↗